Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT05255601
Brief Title: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

First Submitted : February 15, 2022
First Submitted that Met QC Criteria : February 15, 2022
First Posted : February 24, 2022

Last Update Submitted that Met QC Criteria : April 29, 2022
Last Update Posted : May 3, 2022